Skip to content

To Study The Effect Of Vidangadi Lauha Kalp With Madhu In obese Hypothyroidism patient

Study Of Efficacy Of Vidangadi Lauha With Madhu As An Add On Effect In The Management Of Hypothyroidism With Obesity - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076307
Enrollment
30
Registered
2024-11-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases

Interventions

None listed

Sponsors

Shriya Vidhyadhar Kale
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having clinical features of Hypothyroidism. 2.Patients willing to give their consent and participate in the study. 3.Serum TSH level above 4.25mlU/mL. 4.BMI more than or equal to 25 Kg per meter square. 5.Age 18-45 years of either sex. 6.K/C/O Hypothyroidism from less than 10 years. (Anti- Thyroid medications started from at least 3 month before commencement of treatment.)

Exclusion criteria

Exclusion criteria: 1.Patients suffering from Secondary Hypothyroidism, Hashimato Thyroiditis. 2.Pregnancy, lactating mothers. 3.patients having associated diseases like ischemic heart diseases, uncontrolled hypertension, uncontrolled diabetes, myocardial infarction, cerebrovascular events, Cardiac arrhythmias, malignancy and suffering from Psychosis.

Design outcomes

Primary

MeasureTime frame
1.To assess the role of Vidangadi Lauha with madhu on symptoms of Hypothyroidism. 2.To assess the Medohar property of Vidangadi Lauha with madhu (by changes in BMI)Timepoint: 6 weeks

Secondary

MeasureTime frame
To assess the role of Vidangadi Lauha with madhu in Thyroid stimulating activity (by changes in serum TSH level.)Timepoint: 45 days

Countries

India

Contacts

Public ContactVd Prasad V Kulkarni

Government Ayurvedic College Nanded

kulk.prasad1@gmail.com9405365096

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026